Skip to main content
LPCN
NASDAQ Life Sciences

Lipocine Swings to Near-Breakeven as Q3 Revenue Jumps to $2.3M

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.45
Mkt Cap
$11.872M
52W Low
$1.36
52W High
$12.37
52W Position info
6.6% above low
Off High info
88% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LPCN is trading near its 52-week low of $1.36 (6.6% above the low) on light trading volume (0.1× avg).

Summary

Q3 revenue hit $2.3M versus $115K a year earlier, and the net loss narrowed to $0.7M from $3.2M, or 8 cents a share. The revenue is not commercial traction: $2.1M came from license and collaboration revenue, with TLANDO royalties only $190K. Cash and marketable securities stood at $21.5M on September 30 and roughly $28.5M as of November 4, up from $14.9M at December 31, 2025 — a meaningful cushion for a company this size, though the ATM remains open. The operating story is still LPCN 1154: the BLOOM Phase 3 study is expected to enroll about 120 patients, and FDA feedback indicated one positive, well-controlled Phase 3 trial would support an NDA. That trial result, not this quarter's license line, is what determines the equity.

At the time of this announcement, LPCN was trading at $1.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.9M. The 52-week trading range was $1.36 to $12.37. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LPCN - Latest Insights

LPCN
Nov 13, 2026, 3:23 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $1.45 info
Change: -$0.2399 (-14%) info
Market Cap: $16.61M info
LPCN
Nov 05, 2026, 9:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.45 info
Change: -$0.0199 (-1%) info
Market Cap: $16.61M info
LPCN
Oct 07, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.16
Real-time Price: $1.45 info
Change: -$0.7099 (-33%) info
Market Cap: $16.61M info
LPCN
Sep 14, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.27
Real-time Price: $1.45 info
Change: -$0.8199 (-36%) info
Market Cap: $16.61M info
LPCN
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.13
Real-time Price: $1.45 info
Change: -$0.6799 (-32%) info
Market Cap: $16.61M info